Joachim Wiskemann

Joachim Wiskemann holds a PhD and is habilitated in sports and exercise science with an additional academic education in sports psychology. He is employed at the National Center for Tumor Diseases / University Heidelberg and Adjunct Assisstant Professor of Public Health Science at Penn State University. As head of the working group “Exercise Oncology ” (Division of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital) and principal/co-investigator of several exercise intervention trials in cancer patients he has substantial experience in planning and tailoring exercise programs to cancer patients´ needs and capabilities and conducted exercise studies in cancer patients for more than 15 years. Dr. Wiskemann published more than 100 papers in the field including several landmark studies and provided new insights into exercise oncology in a variety of cancer entities. Based on his scientific discoveries, Joachim Wiskemann started early serving the closer and wider Heidelberg cancer community by developing a unique exercise care program for cancer patients offering more than 50 hours of exercise therapy/counselling a week at the National Center for Tumor Diseases in Heidelberg (2010). Further, he established the German-wide expanding network (2011) for high qualitative exercise care in cancer patients (Netzwerk OnkoAktiv; www.netzwerk-onkoaktiv.de). Along this line he also founded the National Expert Group on Physical Activity and Exercise Therapy in Cancer Patients within the German Cancer Society to build national collaborations for larger trials and politicking (2015). Currently, he is leading the S3-Clinical Guideline Initiative of the German Cancer Society on Exercise Oncology with the goal to integrate exercise into routine oncology care. Dr. Wiskemann was honored with the most important German sport science award, the Scientific Award 2017/2018 of the German Olympic Sports Confederation (DOSB), for his habilitation thesis ‘Motor Performance as a Key Parameter in Oncology’. Dr. Wiskemann is a fellow of the ECSS and the ACSM.

Share This Speaker
Speaker Details
  • Profession
    Professor
  • Company
    National Center for Tumour Diseases, Germany
  • Location
Speaker Details
  • Profession
    Professor
  • Company
    National Center for Tumour Diseases, Germany
  • Location